Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-09

Clinical Trial Update: Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the safety of biliary intraductal radiofrequency ablation in patients with unresectable extrahepatic biliary tract ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Bile Duct Cancer | Phase 2 | Status: NOT_YET_RECRUITING